Beacon Pointe Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-11,950
| Closed | -$185K | – | 1365 |
|
2023
Q3 | $185K | Buy |
11,950
+585
| +5% | +$9.05K | ﹤0.01% | 1234 |
|
2023
Q2 | $179K | Sell |
11,365
-1,455
| -11% | -$22.9K | ﹤0.01% | 1015 |
|
2023
Q1 | $211K | Buy |
12,820
+977
| +8% | +$16.1K | ﹤0.01% | 1049 |
|
2022
Q4 | $185K | Buy |
+11,843
| New | +$185K | ﹤0.01% | 1003 |
|
2022
Q3 | – | Sell |
-12,023
| Closed | -$169K | – | 1055 |
|
2022
Q2 | $169K | Buy |
12,023
+162
| +1% | +$2.28K | ﹤0.01% | 980 |
|
2022
Q1 | $170K | Buy |
11,861
+1,190
| +11% | +$17.1K | ﹤0.01% | 1137 |
|
2021
Q4 | $145K | Buy |
+10,671
| New | +$145K | ﹤0.01% | 895 |
|